These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1021623)

  • 1. [Effect of disopyramide on the sino-atrial node].
    Garcia BD; Perez T; Nieto LK
    Kardiologiia; 1976 Mar; 16(3):134-5. PubMed ID: 1021623
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of drugs on "sino-atrial conduction time" and on sinus-node automaticity in man].
    Breithardt G; Seipel L; Höhfeld E; Both A; Loogen F
    Z Kardiol; 1975 Oct; 64(10):895-906. PubMed ID: 56094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of atropine, propafenon and disopyramide on "sino-atrial conduction time" in man].
    Breithardt G; Seipel L; Both A; Loogen F
    Verh Dtsch Ges Inn Med; 1975; 81():1634-7. PubMed ID: 1227042
    [No Abstract]   [Full Text] [Related]  

  • 4. Electrophysiological effects of disopyramide phosphate in patients with sinus node dysfunction.
    Tsuchioka Y; Mitsuda H; Eno S; Fujitani K; Furuta Y; Yoshida M; Miyoshi A; Tateishi H; Satou H
    Jpn Circ J; 1982 Jul; 46(7):693-700. PubMed ID: 6808188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic effect of disopyramide injected into the sinus nodal artery.
    Garcia-Barreto D; Pérez-Medina T
    Acta Physiol Acad Sci Hung; 1977; 49(3-4):231-5. PubMed ID: 755338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic effects of disopyramide and procainamide in open-chest animals].
    Binetti G; Branzi A; Malini PL; Specchia S; Magelli C; Zannoli R; Magnani B
    G Ital Cardiol; 1978; 8(12):1314-9. PubMed ID: 738572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological evaluation of disopyramide in man.
    Josephson ME; Caracta AR; Lau SH; Gallagher JJ; Damato AN
    Am Heart J; 1973 Dec; 86(6):771-80. PubMed ID: 4757788
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disopyramide phosphate: the electrophysiological mechanisms of its anti-arrhythmia action and its use in clinical practice].
    Grosu AA
    Kardiologiia; 1985 May; 25(5):114-8. PubMed ID: 3894756
    [No Abstract]   [Full Text] [Related]  

  • 9. Disopyramide phosphate (Norpace): a new antiarrhythmic drug.
    Yu PN
    Circulation; 1979 Feb; 59(2):236-7. PubMed ID: 758991
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracardiac electrophysiological study of disopyramide in intact and chemically sympathectomized dogs.
    Guimond C; Vasseur C; Godin D; Pelletier B; LeBlanc AR; Nadeau R
    Eur Heart J; 1982 Dec; 3(6):553-63. PubMed ID: 7160394
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of disopyramide on reperfusion arrhythmias in dogs.
    Chagnac A; Pelleg A; Belhassen B; Lubliner J; Vidné B; Laniado S
    J Cardiovasc Pharmacol; 1982; 4(6):994-8. PubMed ID: 6185794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cellular electrophysiologic mechanism of the dual actions of disopyramide on rabbit sinus node function.
    Katoh T; Karagueuzian HS; Jordan J; Mandel WJ
    Circulation; 1982 Dec; 66(6):1216-24. PubMed ID: 7139900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of the antiarrhythmic agent disopyramide phosphate (Norpace).
    Befeler B; Lazzara R
    Heart Lung; 1980; 9(3):475-82. PubMed ID: 6901520
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy and tolerance of disopyramide in arrhythmia associated with sinus node dysfunction].
    Brembilla-Perrot B; Vaur L
    Arch Mal Coeur Vaiss; 1991 Jun; 84(6):837-42. PubMed ID: 1898218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 4 antiarrhythmic drugs on sinoatrial conduction time in isolated and blood-perfused dog atria.
    Shimotori M; Kobayashi M; Chiba S
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):67-79. PubMed ID: 6721625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of Norpace.
    Dean RR
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electrophysiologic study of disopyramide].
    Ponsonnaille J; Marcheix JC; Datchary J; Gras H
    Ann Cardiol Angeiol (Paris); 1979; 28(1):49-52. PubMed ID: 434759
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical development of disopyramide.
    Ankier SI
    Bristol Med Chir J; 1976; 91(339-340):11-2. PubMed ID: 1052317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.